IP Library Granted Patent US 11,696,895
Granted Patent B2
US 11,696,895 · App. 16/959,017 · Granted Jul 11, 2023

Fine particle coating (drug-containing hollow particle and method for manufacturing same)

Inventors: Takumi Asada (Suita, JP); Mitsuaki Kobiki (Kobe, JP)
Assignee: Sumitomo Pharma Co., Ltd.
A61K9/5089A61K9/501A61K9/5015A61K9/5026A61K9/5047
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,696,895
App. No.
16/959,017
Granted
Jul 11, 2023
Kind
B2
Abstract

Provided is a manufacturing method of particles coated with coatable microparticles. The method is a manufacturing method of particles coated with coatable microparticles, comprising the step of adding the coatable microparticles to an inner core comprising a component of interest and a macromolecule, and, while rolling the mixture, coating the mixture while spraying a solvent that can dissolve the macromolecule, wherein the particles coated with the coatable microparticles are coated, component of interest-containing hollow particles.

Claims (11)

1. A method of manufacturing hollow particles coated with coatable microparticles, comprising:

mixing the coatable microparticles with an inner core comprising a component of interest and a macromolecule such that a mixture is obtained; and

performing coating while rolling the mixture and while spraying a solvent that has a property of dissolving the macromolecule, such that hollow particles including the component of interest and coated with the coatable microparticles are obtained,

wherein the inner core has a shell and a hollow section.

2. The method of claim 1 , wherein the coatable microparticles have a D90 value of 100 μm or less.

3. The method of claim 1 , wherein the coatable microparticles have a mean particle size of 25 μm or less.

4. The method of claim 1 , wherein the coatable microparticles have a D100 value of 150 μm or less.

5. The method of claim 1 , wherein the coatable microparticles have a particle size such that all of the coatable microparticles pass through a 100 mesh sieve.

6. The method of claim 1 , wherein the coatable microparticles comprise at least one selected from the group consisting of celluloses, stearic acid, stearate, talc, oil and fat, metal oxide, stearyl fumarate salt, and alginic acid.

7. The method of claim 1 , wherein the coatable microparticles comprise at least one selected from the group consisting of talc, Red Ferric Oxide, Yellow Ferric Oxide, titanium oxide, sodium stearyl fumarate, and sodium stearate.

8. The method of claim 1 , wherein the component of interest is a drug, a cosmetic, an agricultural chemical, a supplement, or a food product.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ERRONEOUS PROPERTY NUMBER PREVIOUSLY RECORDED AT REEL: 059969 FRAME: 0017. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 31, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 062029/0341 →
CHANGE OF NAME Recorded May 12, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 059969/0017 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2020
From: ASADA, TAKUMI; KOBIKI, MITSUAKI
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 053076/0610 →
Priority Claims (1)
JP JP2017-254309 · Dec 28, 2017 · national
Continuity (1)
Related Publication 20200338010A1 · Oct 29, 2020